
@ARTICLE{Brady2017-pw,
  title       = "Combating subclonal evolution of resistant cancer phenotypes",
  author      = "Brady, Samuel W and McQuerry, Jasmine A and Qiao, Yi and
                 Piccolo, Stephen R and Shrestha, Gajendra and Jenkins, David F
                 and Layer, Ryan M and Pedersen, Brent S and Miller, Ryan H and
                 Esch, Amanda and Selitsky, Sara R and Parker, Joel S and
                 Anderson, Layla A and Dalley, Brian K and Factor, Rachel E and
                 Reddy, Chakravarthy B and Boltax, Jonathan P and Li, Dean Y
                 and Moos, Philip J and Gray, Joe W and Heiser, Laura M and
                 Buys, Saundra S and Cohen, Adam L and Johnson, W Evan and
                 Quinlan, Aaron R and Marth, Gabor and Werner, Theresa L and
                 Bild, Andrea H",
  affiliation = "Department of Pharmacology and Toxicology, College of
                 Pharmacy, University of Utah, 30 South 2000 East, Salt Lake
                 City, UT, 84112, USA. Department of Biomedical Informatics,
                 School of Medicine, University of Utah, 421 Wakara Way, Salt
                 Lake City, UT, 84108, USA. Department of Oncological Sciences,
                 School of Medicine, University of Utah, 2000 Circle of Hope
                 Drive, Salt Lake City, UT, 84112, USA. Department of Human
                 Genetics, School of Medicine, University of Utah, 15 South
                 2030 East, Salt Lake City, UT, 84112, USA. Department of
                 Biology, College of Life Sciences, Brigham Young University,
                 Provo, UT, 84602, USA. Division of Computational Biomedicine,
                 School of Medicine, Boston University, 72 East Concord Street,
                 Boston, MA, 02218, USA. Department of Biomedical Engineering,
                 Oregon Health \& Science University, 2730 SW Moody Ave,
                 Portland, OR, 97201, USA. Oregon Center for Spatial Systems
                 Biomedicine, Oregon Health \& Science University, 2730 SW
                 Moody Ave, Portland, OR, 97201, USA. Department of Genetics
                 and Lineberger Comprehensive Cancer Center, University of
                 North Carolina, 450 West Drive, Chapel Hill, NC, 27599, USA.
                 High-Throughput Genomics and Bioinformatic Analysis, Huntsman
                 Cancer Institute, 2000 Circle of Hope Drive, Salt Lake City,
                 UT, 84112, USA. Department of Pathology, Huntsman Cancer
                 Hospital, 1950 Circle of Hope Drive, Salt Lake City, UT,
                 84112, USA. Department of Internal Medicine, Pulmonary
                 Division, School of Medicine, University of Utah, 26 North
                 Medical Drive, Salt Lake City, UT, 84132, USA. Department of
                 Internal Medicine, Huntsman Cancer Institute, University of
                 Utah, 2000 Circle of Hope Drive, Salt Lake City, UT, 84112,
                 USA. Department of Medicine, Oncology Division, Huntsman
                 Cancer Institute, University of Utah, 2000 Circle of Hope
                 Drive, Salt Lake City, UT, 84112, USA. Department of
                 Pharmacology and Toxicology, College of Pharmacy, University
                 of Utah, 30 South 2000 East, Salt Lake City, UT, 84112, USA.
                 andreab@genetics.utah.edu. Department of Biomedical
                 Informatics, School of Medicine, University of Utah, 421
                 Wakara Way, Salt Lake City, UT, 84108, USA.
                 andreab@genetics.utah.edu. Department of Oncological Sciences,
                 School of Medicine, University of Utah, 2000 Circle of Hope
                 Drive, Salt Lake City, UT, 84112, USA.
                 andreab@genetics.utah.edu. Department of Medical Oncology and
                 Therapeutics, City of Hope Comprehensive Cancer Institute,
                 1218 S Fifth Ave, Monrovia, CA, 91016, USA.
                 andreab@genetics.utah.edu.",
  abstract    = "Metastatic breast cancer remains challenging to treat, and
                 most patients ultimately progress on therapy. This acquired
                 drug resistance is largely due to drug-refractory
                 sub-populations (subclones) within heterogeneous tumors. Here,
                 we track the genetic and phenotypic subclonal evolution of
                 four breast cancers through years of treatment to better
                 understand how breast cancers become drug-resistant.
                 Recurrently appearing post-chemotherapy mutations are rare.
                 However, bulk and single-cell RNA sequencing reveal
                 acquisition of malignant phenotypes after treatment, including
                 enhanced mesenchymal and growth factor signaling, which may
                 promote drug resistance, and decreased antigen presentation
                 and TNF-$\alpha$ signaling, which may enable immune system
                 avoidance. Some of these phenotypes pre-exist in pre-treatment
                 subclones that become dominant after chemotherapy, indicating
                 selection for resistance phenotypes. Post-chemotherapy cancer
                 cells are effectively treated with drugs targeting acquired
                 phenotypes. These findings highlight cancer's ability to
                 evolve phenotypically and suggest a phenotype-targeted
                 treatment strategy that adapts to cancer as it evolves.",
  journal     = "Nature communications",
  volume      =  8,
  number      =  1,
  pages       = "1231",
  month       =  nov,
  year        =  2017,
  url         = "http://dx.doi.org/10.1038/s41467-017-01174-3",
  file        = "All Papers/B/Brady et al. 2017 - Combating subclonal evolution of resistant cancer phenotypes.pdf",
  language    = "en",
  issn        = "2041-1723",
  pmid        = "29093439",
  doi         = "10.1038/s41467-017-01174-3",
  pmc         = "PMC5666005"
}


@ARTICLE{Steinbaugh2017-mt,
  title    = "{bcbioRNASeq}: {R} package for bcbio {RNA-seq} analysis",
  author   = "Steinbaugh, Michael J and Pantano, Lorena and Kirchner, Rory D
              and Barrera, Victor and Chapman, Brad A and Piper, Mary E and
              Mistry, Meeta and Khetani, Radhika S and Rutherford, Kayleigh D
              and Hofmann, Oliver and Hutchinson, John N and Sui, Shannan Ho",
  abstract = "RNA-seq analysis involves multiple steps from processing raw
              sequencing data to identifying, organizing, annotating, and
              reporting differentially expressed genes. bcbio is an open
              source, community-maintained framework providing automated and
              scalable RNA-seq methods for identifying gene abundance counts.
              We have developed bcbioRNASeq, a Bioconductor package that
              provides ready-to-render templates and wrapper functions to
              post-process bcbio output data. bcbioRNASeq automates the
              generation of high-level RNA-seq reports, including
              identification of differentially expressed genes, functional
              enrichment analysis and quality control analysis.",
  journal  = "F1000Research",
  volume   =  6,
  month    =  nov,
  year     =  2017,
  url      = "https://f1000research.com/articles/6-1976/v1/pdf",
  file     = "All Papers/S/Steinbaugh et al. 2017 - bcbioRNASeq - R package for bcbio RNA-seq analysis.pdf",
  doi      = "10.12688/f1000research.12093.1"
}


@ARTICLE{Barron2017-eh,
  title       = "A sparse differential clustering algorithm for tracing cell
                 type changes via single-cell {RNA-sequencing} data",
  author      = "Barron, Martin and Zhang, Siyuan and Li, Jun",
  affiliation = "Department of Applied and Computational Mathematics and
                 Statistics, University of Notre Dame, Notre Dame, IN 46556,
                 USA. Department of Biological Sciences, University of Notre
                 Dame, Notre Dame, IN 46556, USA. Mike and Josie Harper Cancer
                 Research Institute, University of Notre Dame, IN 46617, USA.",
  abstract    = "Cell types in cell populations change as the condition
                 changes: some cell types die out, new cell types may emerge
                 and surviving cell types evolve to adapt to the new condition.
                 Using single-cell RNA-sequencing data that measure the gene
                 expression of cells before and after the condition change, we
                 propose an algorithm, SparseDC, which identifies cell types,
                 traces their changes across conditions and identifies genes
                 which are marker genes for these changes. By solving a unified
                 optimization problem, SparseDC completes all three tasks
                 simultaneously. SparseDC is highly computationally efficient
                 and demonstrates its accuracy on both simulated and real data.",
  journal     = "Nucleic acids research",
  month       =  nov,
  year        =  2017,
  url         = "http://dx.doi.org/10.1093/nar/gkx1113",
  file        = "All Papers/B/Barron et al. 2017 - A sparse differential clustering algorithm for tracing cell type changes via single-cell RNA-sequencing data.pdf",
  language    = "en",
  issn        = "0305-1048, 1362-4962",
  pmid        = "29140455",
  doi         = "10.1093/nar/gkx1113"
}

@UNPUBLISHED{Antaki2017-go,
  title    = "{SV2}: Accurate Structural Variation Genotyping and De Novo
              Mutation Detection",
  author   = "Antaki, Danny and Brandler, William M and Sebat, Jonathan",
  abstract = "Structural Variation (SV) detection from short-read whole genome
              sequencing is error prone, presenting significant challenges for
              population or family-based studies of disease. Here we describe
              SV2, a machine-learning algorithm for genotyping deletions and
              duplications from paired-end sequencing data. SV2 can rapidly
              integrate variant calls from multiple structural variant
              discovery algorithms into a unified call set with high genotyping
              accuracy and capability to detect de novo mutations.",
  journal  = "bioRxiv",
  pages    = "113498",
  month    =  nov,
  year     =  2017,
  url      = "https://www.biorxiv.org/content/early/2017/11/17/113498?%3Fcollection=",
  file     = "All Papers/A/Antaki et al. 2017 - SV2 - Accurate Structural Variation Genotyping and De Novo Mutation Detection.pdf",
  language = "en",
  doi      = "10.1101/113498"
}

@UNPUBLISHED{Sauria2017-vw,
  title    = "{QuASAR}: Quality Assessment of Spatial Arrangement
              Reproducibility in {Hi-C} Data",
  author   = "Sauria, Michael E G and Taylor, James",
  abstract = "Hi-C has revolutionized global interrogation of chromosome
              conformation, however there are few tools to assess the
              reliability of individual experiments. Here we present a new
              approach, QuASAR, for measuring quality within and between Hi-C
              samples. We show that QuASAR can detect even tiny fractions of
              noise and estimate both return on additional sequencing and
              quality upper bounds. We also demonstrate QuASAR9s utility in
              measuring replicate agreement across feature resolutions.
              Finally, QuASAR can estimate resolution limits based on both
              internal and replicate quality scores. QuASAR provides an
              objective means of Hi-C sample comparison while providing context
              and limits to these measures.",
  journal  = "bioRxiv",
  pages    = "204438",
  month    =  nov,
  year     =  2017,
  url      = "https://www.biorxiv.org/content/early/2017/11/14/204438?%3Fcollection=",
  file     = "All Papers/S/Sauria and Taylor 2017 - QuASAR - Quality Assessment of Spatial Arrangement Reproducibility in Hi-C Data.pdf",
  language = "en",
  doi      = "10.1101/204438"
}

@ARTICLE{Jurtz2017-pu,
  title       = "An introduction to deep learning on biological sequence data:
                 examples and solutions",
  author      = "Jurtz, Vanessa Isabell and Johansen, Alexander Rosenberg and
                 Nielsen, Morten and Almagro Armenteros, Jose Juan and Nielsen,
                 Henrik and S{\o}nderby, Casper Kaae and Winther, Ole and
                 S{\o}nderby, S{\o}ren Kaae",
  affiliation = "Department of Bio and Health Informatics. Department of
                 Applied Mathematics and Computer Science, Technical University
                 of Denmark, Lyngby, Denmark. Instituto de Investigaciones
                 Biotecnol{\'o}gicas, Universidad Nacional de San Mart{\'\i}n,
                 Buenos Aires, Argentina. Department of Biology, University of
                 Copenhagen, Copenhagen, Denmark.",
  abstract    = "Motivation: Deep neural network architectures such as
                 convolutional and long short-term memory networks have become
                 increasingly popular as machine learning tools during the
                 recent years. The availability of greater computational
                 resources, more data, new algorithms for training deep models
                 and easy to use libraries for implementation and training of
                 neural networks are the drivers of this development. The use
                 of deep learning has been especially successful in image
                 recognition; and the development of tools, applications and
                 code examples are in most cases centered within this field
                 rather than within biology. Results: Here, we aim to further
                 the development of deep learning methods within biology by
                 providing application examples and ready to apply and adapt
                 code templates. Given such examples, we illustrate how
                 architectures consisting of convolutional and long short-term
                 memory neural networks can relatively easily be designed and
                 trained to state-of-the-art performance on three biological
                 sequence problems: prediction of subcellular localization,
                 protein secondary structure and the binding of peptides to MHC
                 Class II molecules. Availability and implementation: All
                 implementations and datasets are available online to the
                 scientific community at
                 https://github.com/vanessajurtz/lasagne4bio. Contact:
                 skaaesonderby@gmail.com. Supplementary information:
                 Supplementary data are available at Bioinformatics online.",
  journal     = "Bioinformatics",
  volume      =  33,
  number      =  22,
  pages       = "3685--3690",
  month       =  nov,
  year        =  2017,
  url         = "http://dx.doi.org/10.1093/bioinformatics/btx531",
  language    = "en",
  issn        = "1367-4803, 1367-4811",
  pmid        = "28961695",
  doi         = "10.1093/bioinformatics/btx531"
}


@ARTICLE{Hicks2017-mx,
  title       = "Missing data and technical variability in single-cell
                 {RNA-sequencing} experiments",
  author      = "Hicks, Stephanie C and Townes, F William and Teng, Mingxiang
                 and Irizarry, Rafael A",
  affiliation = "Department of Biostatistics, Harvard T. H. Chan School of
                 Public Health, Boston, MA, USA and Department of Biostatistics
                 and Computational Biology, Dana-Farber Cancer Institute,
                 Boston, MA, USA. Department of Biostatistics, Harvard T.H.
                 Chan School of Public Health, Boston, MA, USA. Department of
                 Biostatistics, Harvard T.H. Chan School of Public Health,
                 Boston, MA, USA and Department of Biostatistics and
                 Computational Biology, Dana-Farber Cancer Institute, Boston,
                 MA, USA.",
  abstract    = "Until recently, high-throughput gene expression technology,
                 such as RNA-Sequencing (RNA-seq) required hundreds of
                 thousands of cells to produce reliable measurements. Recent
                 technical advances permit genome-wide gene expression
                 measurement at the single-cell level. Single-cell RNA-Seq
                 (scRNA-seq) is the most widely used and numerous publications
                 are based on data produced with this technology. However,
                 RNA-seq and scRNA-seq data are markedly different. In
                 particular, unlike RNA-seq, the majority of reported
                 expression levels in scRNA-seq are zeros, which could be
                 either biologically-driven, genes not expressing RNA at the
                 time of measurement, or technically-driven, genes expressing
                 RNA, but not at a sufficient level to be detected by
                 sequencing technology. Another difference is that the
                 proportion of genes reporting the expression level to be zero
                 varies substantially across single cells compared to RNA-seq
                 samples. However, it remains unclear to what extent this
                 cell-to-cell variation is being driven by technical rather
                 than biological variation. Furthermore, while systematic
                 errors, including batch effects, have been widely reported as
                 a major challenge in high-throughput technologies, these
                 issues have received minimal attention in published studies
                 based on scRNA-seq technology. Here, we use an assessment
                 experiment to examine data from published studies and
                 demonstrate that systematic errors can explain a substantial
                 percentage of observed cell-to-cell expression variability.
                 Specifically, we present evidence that some of these reported
                 zeros are driven by technical variation by demonstrating that
                 scRNA-seq produces more zeros than expected and that this bias
                 is greater for lower expressed genes. In addition, this
                 missing data problem is exacerbated by the fact that this
                 technical variation varies cell-to-cell. Then, we show how
                 this technical cell-to-cell variability can be confused with
                 novel biological results. Finally, we demonstrate and discuss
                 how batch-effects and confounded experiments can intensify the
                 problem.",
  journal     = "Biostatistics",
  month       =  nov,
  year        =  2017,
  url         = "http://dx.doi.org/10.1093/biostatistics/kxx053",
  file        = "All Papers/H/Hicks et al. 2017 - Missing data and technical variability in single-cell RNA-sequencing experiments.pdf",
  keywords    = "Censoring; Confounding; Genomics; Missing not at random
                 (MNAR); Single-cell RNA-Sequencing; Sparsity",
  language    = "en",
  issn        = "1465-4644, 1468-4357",
  pmid        = "29121214",
  doi         = "10.1093/biostatistics/kxx053"
}


% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Huang2017-mr,
  title       = "{mSignatureDB}: a database for deciphering mutational
                 signatures in human cancers",
  author      = "Huang, Po-Jung and Chiu, Ling-Ya and Lee, Chi-Ching and Yeh,
                 Yuan-Ming and Huang, Kuo-Yang and Chiu, Cheng-Hsun and Tang,
                 Petrus",
  affiliation = "Department of Biomedical Sciences, Chang Gung University,
                 Taoyuan, Taiwan. Genomic Medicine Research Core Laboratory,
                 Chang Gung Memorial Hospital, Linkou, Taiwan. Molecular
                 Medicine Research Center, Chang Gung University, Taoyuan,
                 Taiwan. Department and Graduate Institute of Computer Science
                 and Information Engineering, Chang Gung University, Taoyuan,
                 Taiwan. Graduate Institute of Pathology and Parasitology,
                 National Defense Medical Center, Taipei, Taiwan. Molecular
                 Infectious Disease Research Center, Chang Gung Memorial
                 Hospital, Linkou, Taiwan.",
  abstract    = "Cancer is a genetic disease caused by somatic mutations;
                 however, the understanding of the causative biological
                 processes generating these mutations is limited. A cancer
                 genome bears the cumulative effects of mutational processes
                 during tumor development. Deciphering mutational signatures in
                 cancer is a new topic in cancer research. The Wellcome Trust
                 Sanger Institute (WTSI) has categorized 30 reference
                 signatures in the COSMIC database based on the analyses of âˆ¼10
                 000 sequencing datasets from TCGA and ICGC. Large cohorts and
                 bioinformatics skills are required to perform the same
                 analysis as WTSI. The quantification of known signatures in
                 custom cohorts is not possible under the current framework of
                 the COSMIC database, which motivates us to construct a
                 database for mutational signatures in cancers and make such
                 analyses more accessible to general researchers. mSignatureDB
                 (http://tardis.cgu.edu.tw/msignaturedb) integrates R packages
                 and in-house scripts to determine the contributions of the
                 published signatures in 15 780 individual tumors from 73
                 TCGA/ICGC cancer projects, making comparison of signature
                 patterns within and between projects become possible.
                 mSignatureDB also allows users to perform signature analysis
                 on their own datasets, quantifying contributions of signatures
                 at sample resolution, which is a unique feature of
                 mSignatureDB not available in other related databases.",
  journal     = "Nucleic acids research",
  month       =  nov,
  year        =  2017,
  url         = "http://dx.doi.org/10.1093/nar/gkx1133",
  file        = "All Papers/H/Huang et al. 2017 - mSignatureDB - a database for deciphering mutational signatures in human cancers.pdf",
  language    = "en",
  issn        = "0305-1048, 1362-4962",
  pmid        = "29145625",
  doi         = "10.1093/nar/gkx1133"
}

@UNPUBLISHED{Cui2017-fy,
  title    = "Boosting Gene Expression Clustering with {System-Wide} Biological
              Information: A Robust Autoencoder Approach",
  author   = "Cui, Hongzhu and Zhou, Chong and Dai, Xinyu and Liang, Yuting and
              Paffenroth, Randy and Korkin, Dmitry",
  abstract = "Gene expression analysis provides genome-wide insights into the
              transcriptional activity of a cell. One of the first
              computational steps in exploration and analysis of the gene
              expression data is clustering. With a number of standard
              clustering methods routinely used, most of the methods do not
              take prior biological information into account. In this paper, we
              propose a new approach for gene expression clustering analysis.
              The approach benefits from a new deep learning architecture,
              Robust Autoencoder, which provides a more accurate high-level
              representation of the feature sets, and from incorporating prior
              biological information into the clustering process. We tested our
              approach on two distinct gene expression datasets and compared
              the performance with two widely used clustering methods,
              hierarchical clustering and k-means, as well as with a recent
              deep learning clustering approach. As a result, our approach
              outperformed all other clustering methods on the labeled yeast
              gene expression dataset. Furthermore we showed that it is better
              in identifying the functionally common clusters than k-means on
              the unlabeled human gene expression dataset. The results
              demonstrate that our new deep learning architecture could
              generalize well the specific properties of gene expression
              profiles. Furthermore, the results confirm our hypothesis that
              the prior biological network knowledge could be helpful in the
              gene expression clustering task.",
  journal  = "bioRxiv",
  pages    = "214122",
  month    =  nov,
  year     =  2017,
  url      = "https://www.biorxiv.org/content/early/2017/11/05/214122?%3Fcollection=",
  file     = "All Papers/C/Cui et al. 2017 - Boosting Gene Expression Clustering with System-Wide Biological Information - A Robust Autoencoder Approach.pdf",
  language = "en",
  doi      = "10.1101/214122"
}

@UNPUBLISHED{Spill2017-xz,
  title    = "Binless normalization of {Hi-C} data provides significant
              interaction and difference detection independently of resolution",
  author   = "Spill, Yannick G and Castillo, David and Marti-Renom, Marc A",
  abstract = "3C-like experiments, such as 4C or Hi-C, have been fundamental in
              understanding genome organization. Thanks to these technologies,
              it is now known, for example, that Topologically Associating
              Domains (TADs) and chromatin loops are implicated in the dynamic
              interplay of gene activation and repression, and their disruption
              can have dramatic effects on embryonic development. To make their
              detection easier, scientists have endeavored into deeper
              sequencing to mechanically increase the chances to detect weaker
              signals such as chromatin loops. Part of this mindset can be
              attributed to the limitations of existing software: the analysis
              of Hi-C experiments is both statistically and computationally
              demanding. Here, we devise a new way to represent Hi-C data,
              which leads to a more detailed classification of paired-end reads
              and, ultimately, to a new normalization and interaction detection
              method. Unlike any other, Binless is resolution-agnostic, and
              adapts to the quality and quantity of available data. We
              demonstrate its capacities to call interactions and differences
              and make the software freely available.",
  journal  = "bioRxiv",
  pages    = "214403",
  month    =  nov,
  year     =  2017,
  url      = "https://www.biorxiv.org/content/early/2017/11/05/214403?%3Fcollection=",
  file     = "All Papers/S/Spill et al. 2017 - Binless normalization of Hi-C data provides significant interaction and difference detection independently of resolution.pdf",
  language = "en",
  doi      = "10.1101/214403"
}

@ARTICLE{Hu2017-jo,
  title       = "{TumorFusions}: an integrative resource for cancer-associated
                 transcript fusions",
  author      = "Hu, Xin and Wang, Qianghu and Tang, Ming and Barthel, Floris
                 and Amin, Samirkumar and Yoshihara, Kosuke and Lang, Frederick
                 M and Martinez-Ledesma, Emmanuel and Lee, Soo Hyun and Zheng,
                 Siyuan and Verhaak, Roel G W",
  affiliation = "Department of Genomic Medicine, The University of Texas MD
                 Anderson Cancer Center, Houston, TX 77030, USA. Program in
                 Bioinformatics and Biostatistics, The University of Texas
                 Graduate School of Biomedical Sciences, Houston, TX 77030,
                 USA. Department of Bioinformatics and Computational Biology,
                 The University of Texas MD Anderson Cancer Center, Houston, TX
                 77030, USA. The Jackson Laboratory for Genomic Medicine,
                 Farmington, CT 06032, USA. Department of Obstetrics and
                 Gynecology, Niigata University Graduate School of Medical and
                 Dental Sciences, Niigata, 951-8510, Japan. Department of
                 Neuro-Oncology, The University of Texas MD Anderson Cancer
                 Center, Houston, TX 77030, USA.",
  abstract    = "Gene fusion represents a class of molecular aberrations in
                 cancer and has been exploited for therapeutic purposes. In
                 this paper we describe TumorFusions, a data portal that
                 catalogues 20 731 gene fusions detected in 9966 well
                 characterized cancer samples and 648 normal specimens from The
                 Cancer Genome Atlas (TCGA). The portal spans 33 cancer types
                 in TCGA. Fusion transcripts were identified via a uniform
                 pipeline, including filtering against a list of 3838
                 transcript fusions detected in a panel of 648 non-neoplastic
                 samples. Fusions were mapped to somatic DNA rearrangements
                 identified using whole genome sequencing data from 561 cancer
                 samples as a means of validation. We observed that 65\% of
                 transcript fusions were associated with a chromosomal
                 alteration, which is annotated in the portal. Other features
                 of the portal include links to SNP array-based copy number
                 levels and mutational patterns, exon and transcript level
                 expressions of the partner genes, and a network-based
                 centrality score for prioritizing functional fusions. Our
                 portal aims to be a broadly applicable and user friendly
                 resource for cancer gene annotation and is publicly available
                 at http://www.tumorfusions.org.",
  journal     = "Nucleic acids research",
  month       =  nov,
  year        =  2017,
  url         = "http://dx.doi.org/10.1093/nar/gkx1018",
  file        = "All Papers/H/Hu et al. 2017 - TumorFusions - an integrative resource for cancer-associated transcript fusions.pdf",
  language    = "en",
  issn        = "0305-1048, 1362-4962",
  pmid        = "29099951",
  doi         = "10.1093/nar/gkx1018"
}
